Suchergebnisse - "Dolgikh, Nadezda"

PubPharm (10)

1

Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax

enthalten in: Haematologica | 2023

von Rausch, J. | Dzama, M. | Dolgikh, N. | +13

2

Co-targeting MCL-1 and ERK1/2 kinase induces mitochondrial apoptosis in rhabdomyosarcoma cells

enthalten in: Translational oncology | 2022

von Winkler, M. | Friedrich, J. | Boedicker, C. | +1

3

Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells

enthalten in: Neoplasia (New York, N.Y.) | 2022

von Erdogdu, U. | Dolgikh, N. | Laszig, S. | +5

4

Smac mimetics and TRAIL cooperate to induce MLKL-dependent necroptosis in Burkitt's lymphoma cell lines

enthalten in: Neoplasia (New York, N.Y.) | 2021

von Koch, A. | Jeiler, B. | Roedig, J. | +3

5

The IRE1 and PERK arms of the unfolded protein response promote survival of rhabdomyosarcoma cells

enthalten in: Cancer letters | 2020

von McCarthy, N. | Dolgikh, N. | Logue, S. | +5

6

Co-inhibition of BET proteins and PI3Kα triggers mitochondrial apoptosis in rhabdomyosarcoma cells

enthalten in: Oncogene | 2020

von Boedicker, C. | Hussong, M. | Grimm, C. | +7

7

Targeting ferroptosis in rhabdomyosarcoma cells

enthalten in: International journal of cancer | 2020

von Dächert, J. | Ehrenfeld, V. | Habermann, K. | +2

8

Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD

enthalten in: International journal of molecular sciences | 2019

von Fadeev, R. | Chekanov, A. | Solovieva, M. | +9

9

NRAS-Mutated Rhabdomyosarcoma Cells Are Vulnerable to Mitochondrial Apoptosis Induced by Coinhibition of MEK and PI3Kα

enthalten in: Cancer research | 2018

von Dolgikh, N. | Hugle, M. | Vogler, M. | +1

10

Rhabdomyosarcoma cells are susceptible to cell death by LDK378 alone or in combination with sorafenib independently of anaplastic lymphoma kinase status

enthalten in: Anti-cancer drugs | 2017

von Dolgikh, N. | Fulda, S.

1
[1]